Preclinical in vivo and/or in vitro experiments have discovered a large number of drugs that inhibit NF-κB signaling and thus alleviate the development of endometriosis (Table 1)13, 14, 16, 18, 19, 36, 46, 67, 75, 87, 88, 91-119. This evidence concerns the gene NFKB1 and endometriosis.